Merete Lund Hetland

Merete Lund Hetland

Clinical Professor

Member of:

  • Internal Medicine: Rheumatology


Publication year:
All
1 - 10 out of 38Page size: 10
  1. 2012
  2. Published

    CD6 and syntaxin binding protein 6 variants and response to tumor necrosis factor alpha inhibitors in Danish patients with rheumatoid arthritis

    Krintel, S. B., Essioux, L., Wool, A., Johansen, J. S., Schreiber, E., Zekharya, T., Akiva, P., Østergaard, Mikkel & Hetland, Merete Lund, 2012

    Research output: Other contribution › Net publication - Internet publication › Research › peer-review

  3. Published

    Clinical response, drug survival and predictors thereof among 548 switchers of tumor necrosis factor alpha inhibitor therapy in psoriatic arthritis. Results from the Danish nationwide Danbio Registry.

    Glintborg, B., Østergaard, Mikkel, Krogh, N. S., Andersen, M. D., Tarp, U., Loft, A. G., Lindegaard, H. M., Holland-Fischer, M., Nordin, H., Jensen, D. V. & Hetland, Merete Lund, 2012, In: Arthritis & Rheumatism. 64, 10 suppl., p. S1081 1 p.

    Research output: Contribution to journal › Conference abstract in journal › Research › peer-review

  4. Published

    Clinical response, drug survival and predictors thereof in 432 ankylosing spondylitis patients switching tumor necrosis factor α inhibitor therapy: Results from the Danish nationwide DANBIO registry.

    Glintborg, B., Østergaard, Mikkel, Krogh, N. S., Tarp, U., Manilo, N., Loft, A. G., Hansen, A., Schlemmer, A., Fana, V., Lindegaard, H. M., Nordin, H., Rasmussen, C., Ejstrup, L., Jensen, D. V., Mosborg-Petersen, P. & Hetland, Merete Lund, 2012, In: Scandinavian Journal of Rheumatology. Supplement. 41, 126 suppl., p. 40-1 2 p.

    Research output: Contribution to journal › Conference abstract in journal › Research › peer-review

  5. Published

    Clinical response, drug survival and predictors thereof in 432 patients with ankylosing spondylitis switching anti tumor necrosis factor α therapy: Results from the Danish nationwide Danbio registry

    Glintborg, B., Østergaard, Mikkel, Krogh, N., Tarp, U., Loft, A., Hansen, A., Schlemmer, A., Fana, V., Kristensen, M., Lindegaard, H. M., Nordin, H., Rasmussen, C., Ejstrup, L., Petersen, P. M., Manilo, N., Jensen, D. V. & Hetland, Merete Lund, 2012, In: Annals of the Rheumatic Diseases. 71, Suppl. 3, p. 111 1 p.

    Research output: Contribution to journal › Conference abstract in journal › Research › peer-review

  6. Published

    DANBIO: Dansk Reumatologisk Database

    Hetland, Merete Lund, Jensen, D. V. & Tarp, U., 2012, In: Ugeskrift for Laeger. 174, 42, p. 2520

    Research output: Contribution to journal › Journal article › Research › peer-review

  7. Published

    DANBIO Årsrapport 2011

    Hetland, Merete Lund & Jensen, D. V., 2012, GP-Tryk A/S. 106 p.

    Research output: Book/Report › Report › Research › peer-review

  8. Published

    Does dynamic contrast-enhanced MRI provide better separation of active early rheumatoid arthritis patients and healthy controls than conventional MRI?

    Axelsen, M. B., Ejbjerg, B. J., Hetland, Merete Lund, Hørslev-Petersen, K., Lauridsen, U. B., Majgaard, O., Boesen, M., Kubassova, O., Bliddal, Henning & Østergaard, Mikkel, 2012, In: Annals of the Rheumatic Diseases. 71, 3 suppl., p. 604-5 2 p.

    Research output: Contribution to journal › Conference abstract in journal › Research › peer-review

  9. Published

    Dynamic contrast-enhanced magnetic resonance imaging of the wrist in rheumatoid arthritis patients treated with methotrexate, intra-articular glucocorticoid and adalimumab/placebo.

    Axelsen, M. B., Hetland, Merete Lund, Hørslev-Petersen, K., Stengaard-Pedersen, K., Junker, P., Pødenphant, J., Møller, J. M., Bliddal, Henning, Kubassova, O., Boesen, M. & Østergaard, Mikkel, 2012, In: Arthritis & Rheumatism. 64, 10 suppl., p. S452-3 2 p.

    Research output: Contribution to journal › Conference abstract in journal › Research › peer-review

  10. Published

    Dyslipidaemia in early rheumatoid arthritis patients is common and not influenced by two years of effective DMARD therapy. The Opera study.

    Ellingsen, T., Hørslev-Petersen, K., Hetland, Merete Lund, Junker, P., Pødenphanth, J., Østergaard, Mikkel & Stengaard-Pedersen, K., 2012, In: Arthritis & Rheumatism. 64, 10 suppl., p. S181 1 p.

    Research output: Contribution to journal › Conference abstract in journal › Research › peer-review

  11. Published

    Effectiveness of disease-modifying antirheumatic drug co-therapy with methotrexate and leflunomide in rituximab-treated rheumatoid arthritis patients: results of a 1-year follow-up study from the CERERRA collaboration

    Chatzidionysiou, K., Lie, E., Nasonov, E., Lukina, G., Hetland, Merete Lund, Tarp, U., van Riel, P. L. C. M., Nordström, D. C., Gomez-Reino, J., Pavelka, K., Tomsic, M., Kvien, T. K., van Vollenhoven, R. F. & Gabay, C., 2012, In: Annals of the Rheumatic Diseases. 71, 3, p. 374-377 4 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

Previous 1 2 3 4 Next

ID: 922207